[Determinants and prognosis of ischemic mitral regurgitation]

D Messika-Zeitoun1, S F Yiu, F Grigioni

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, 200, First Street S.W., Rochester, 55905 MN, USA.

Annales De Cardiologie Et D'Angeiologie
|May 21, 2003
PubMed

Insights

Ischemic mitral regurgitation (IMR), a complication of coronary artery disease, often occurs after myocardial infarction. Its severity relates to left ventricular remodeling, and high-risk IMR is linked to increased mortality.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomedical Engineering

Context:

  • Ischemic mitral regurgitation (IMR) is a significant complication of coronary artery disease (CAD).
  • Functional IMR, distinct from acute rupture, arises from left ventricular remodeling post-myocardial infarction (MI), affecting 15-20% of patients.
  • This condition is often underestimated due to subtle murmur intensity but carries prognostic implications.

Purpose:

  • To elucidate the mechanisms and clinical significance of functional ischemic mitral regurgitation.
  • To highlight the relationship between left ventricular remodeling and IMR severity.
  • To discuss current treatment strategies and their limitations.

Summary:

  • Functional IMR results from apical and posterior papillary muscle displacement and loss of systolic annular contraction, leading to excessive valvular tenting.
  • The degree of regurgitation, quantified by regurgitant volume (≥30 ml) or effective regurgitant orifice (≥20 mm2), defines a high-risk group with excess mortality.
  • Current management often involves ring annuloplasty, which may not address underlying ventricular remodeling, questioning its long-term efficacy.

Impact:

  • IMR significantly increases mortality risk, directly correlated with regurgitation severity.
  • Identifying high-risk patients is crucial for guiding therapeutic decisions.
  • Further research is needed to develop treatments that address the underlying ventricular remodeling for improved long-term outcomes in IMR.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...